… The availability of prophylactic human papillomavirus (HPV) vaccines has provided …
vaccines have each been licensed in over 100 countries. By the beginning of 2012, HPV vaccine …

… Human papillomavirus (HPV) infection causes virtually all … This Review examines prophylactic
HPV subunit vaccines based on … are developing commercial versions of the vaccine. Both …

… Countries with a human papillomavirus vaccine in their immunisation programme, 2014 …
human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study …

… effect of a male vaccination program on female human papillomavirus (HPV) infection rates
and cervical cancer incidence, we needed to directly model the effect of vaccination on HPV …

… Human papillomavirus (HPV) vaccines are among the most effective prophylactic vaccines
available and have established several important landmarks in human vaccinology. They are …

The papers are reviewed by external experts and WHO staff, and reviewed and endorsed by
the WHO Strategic Advisory Group of Experts (SAGE) on immunization (http://www. who. int/…

We present a transmission dynamic model that can assess the epidemiologic consequences
and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent (…

Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past …
vaccines, focusing on vaccine coverage and efficacy. In addition, pan-gender vaccination …

… The anticipated licensure within the next three months of a vaccine against human
papillomavirus (HPV) would represent a major public health advance against cervical cancer …

… human papillomavirus vaccination in the UK. Our model considers the impact of vaccination
… human papillomavirus types not in the vaccine, non-cervical cancers, and anogenital warts. …